Effect of pirfenidone against vanadate-induced kidney fibrosis in rats (Q44046881)

29 November 2017

title

Effect of pirfenidone against vanadate-induced kidney fibrosis in rats (English)

1 reference

29 November 2017

author name string

Mohammed Ali Al-Bayati

1

1 reference

29 November 2017

Yan Xie

2

1 reference

29 November 2017

F Charles Mohr

3

1 reference

29 November 2017

Solomon B Margolin

4

1 reference

29 November 2017

Shri N Giri

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

29 November 2017

published in

Biochemical Pharmacology

1 reference

29 November 2017

volume

64

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

517-525

1 reference

Long-term outcome in children and adults with classic focal segmental glomerulosclerosis

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Fibrosis causes progressive kidney failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Focal sclerosing glomerulopathy risk factors of progression and optimal mode of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Pirfenidone improves renal function and fibrosis in the post-obstructed kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Use of a single tissue extract to determine cellular protein and nucleic acid concentrations and rate of amino acid incorporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Increases in lung prolyl hydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Vanadate-induced nitric oxide production: role in osteoblast growth and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Evidence for free radical involvement in the hydroxylation of proline: inhibition by nitro blue tetrazolium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Occurrence of lipid peroxidation in brain microsomes in the presence of NADH and vanadate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Vanadyl- and vanadate-induced lipid peroxidation in mitochondria and in phosphatidylcholine suspensions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Bleomycin regulation of transforming growth factor-beta mRNA in rat lung fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Expression of transforming growth factor-beta isoforms in human glomerular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Function and activation of NF-kappa B in the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Redox regulation of transcriptional activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

Arsenic induces oxidant stress and NF-KB activation in cultured aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901213-3

10.1016/S0006-2952(02)01213-3

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference